Julia Gómez

Dolutegravir plus rilpivirine: benefits beyond viral suppression

J. Troya, C. Galera, M. Montero, 2022, Medicine.

Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic

J. Troya, L. Rodríguez, J. Iribarren, 2023, Viruses.